✦ LIBER ✦

Etoposide (VP-16) and cytosine arabinoside in the treatment of relapsed small-cell lung cancer

Book ID: 123068079
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 162 KB
Volume: 5
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(89)90444-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin (CBDCA) plus etoposide (VP-1

Carboplatin (CBDCA) plus etoposide (VP-16) in non small cell lung cancer (NSCLC) treatment

✍ Bernardo, G.; Bernardo, A.; Plastina, M.; Strada, M.R.; Brunetti, G.; Pozzi, U.; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

High-dose VP-16 with intermediate-dose c

High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia

✍ Hon Y. Chan; Frederick J. Meyers; Jerry P. Lewis 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 147 KB

Carboplatin (CBDOA) plus etoposide (VP16

Carboplatin (CBDOA) plus etoposide (VP16) and vicristine (VCR) in treatment of Small Cell Lung Cancer (SCLC)

✍ Crinò, L.; De Marinis, F.; Clerici, M.; Meacci, M.; Cocconi, G.; Malacarne, P.; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 131 KB

The role of RAD51 in etoposide (VP16) re

The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer

✍ Lasse Tengbjerg Hansen; Cecilia Lundin; Mogens Spang-Thomsen; Lone Nørgård Peter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 465 KB

## Abstract Etoposide (VP16) is a potent inducer of DNA double‐strand breaks (DSBs) and is efficiently used in small cell lung cancer (SCLC) therapy. However, acquired VP16 resistance remains an important barrier to effective treatment. To understand the underlying mechanisms for VP16 resistance in

Etoposide (VP-16) scheduling in small ce

Etoposide (VP-16) scheduling in small cell lung cancer (SCLC), laboratory rationale and clinical results

✍ Falk, S.J.; Smith, P.J.; Osborne, R.J.; Bleehen, N.M. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Carboplatin, epirubicin, and VP-16 chemo

Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 144 KB